Imelda Dacones, MD, president and CEO of Northwest Permanente, focuses on health disparities and the role of physicians and all of health care to curb injustice.
Collaboration between Kaiser Permanente’s care delivery system and research programs has driven the successful implementation of remdesivir clinical trials across regions.
Kaiser Permanente’s clinical trials help advance treatment for health conditions and diseases ranging from heart disease and cancer to AIDS and COVID-19.
The 55-Word Stories campaign is an initiative that provides Permanente physicians with a creative outlet to share how COVID-19 has impacted their practice and/or personal life.
Pediatrician Kerstin Rosen, MD, of The Permanente Medical Group, designed a face shield for health care workers and enlisted the help of the 3D printing community.
In an effort to improve understanding and clinical practice guidelines around the novel coronavirus, Kaiser Permanente’s various research centers are quickly moving to investigate potential treatment for COVID-19.